PNAS published a peer-reviewed study detailing antimalarial cytoskeletal targeting with broad apicomplexan activity.
The journal released the findings under the DOI 10.1073/pnas.2608709123?af=R on July 24, 2026, at 07:00:00Z.
PNAS did not disclose clinical trial timelines or chemical structures for the compounds involved in the study.
